OJI> Vol.2 No.2, June 2012

The law of unintended consequences and antibiotics

DownloadDownload as PDF (Size:454KB) Full-Text HTML PP. 59-64   DOI: 10.4236/oji.2012.22007

ABSTRACT

Antibiotic therapy has been of unquestionable value in terms of saving lives and reducing suffering caused by infectious diseases. However, the widespread and indiscriminant use of antibiotics has not been without significant consequences. Some of these consequences include increased antibiotic resistance in pathogenic strains of bacteria. In addition, the indiscriminate use of antibiotics has recently been shown to alter the host microbiota and this has been associated with chronic disease. However, abandoning the use of antibiotics would be unthinkable. We have been exploring a strategy of modulating the host tolerance/resistance mechanisms as a means to ablate infection. We postulate that the obvious advantage of this therapeutic strategy is that, by targeting host tolerance/resistance mechanisms, the selective pressure for the expression of pathogen resistance is greatly reduced or altogether absent.

KEYWORDS


Cite this paper

Thacker, J. and Artlett, C. (2012) The law of unintended consequences and antibiotics. Open Journal of Immunology, 2, 59-64. doi: 10.4236/oji.2012.22007.

References

[1] Taubes, G. (2008) The bacteria fight back. Science, 321, 356-361. doi:10.1126/science.321.5887.356
[2] Klevens, R.M., Morrison, M.A., Nadle, J., Petit, S., Gershman, K., Ray, S., et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA, 298, 1763-1771. doi:10.1001/jama.298.15.1763
[3] Bancroft, E.A. (2007) Antimicrobial resistance: It’s not just for hospitals. JAMA, 298, 1803-1804. doi:10.1001/jama.298.15.1803
[4] D’Agata, E.M., Webb, G.F., Horn, M.A., Moellering, R.C. and Ruan, S. (2009) Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clinical Infectious Diseases, 48, 274-284. doi:10.1086/595844
[5] Farley, J.E. (2008) Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. Journal of the American Academy of Nurse Practitioners, 20, 85-92. doi:10.1111/j.1745-7599.2007.00290.x
[6] Wright, G.D. (2010) Antibiotic resistance: Where does it come from and what can we do about it? BMC Biology, 8, 123. doi:10.1186/1741-7007-8-123
[7] D’Costa V.M., King, C.E., Kalan, L., Morar, M., Sung, W.W., Schwarz, C., et al. (2011) Antibiotic resistance is ancient. Nature, 477, 457-461. doi:10.1038/nature10388
[8] Bennett, P.M. (2008) Plasmid encoded antibiotic resistance: Acquisition and transfer of antibiotic resistance genes in bacteria. British Journal of Pharmacology, 153, S347-S357. doi:10.1038/sj.bjp.0707607
[9] Ohnishi, M., Golparian, D., Shimuta, K., Saika, T., Hoshina, S., Iwasaku, K., et al. (2011) Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrobial Agents and Chemotherapy, 55, 3538-3545. doi:10.1128/AAC.00325-11
[10] Dethlefsen, L., Fall-Ngai, M. and Relman, D.A. (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature, 449, 811-818. doi:10.1038/nature06245
[11] Blaser, M.J. and Kirschner, D. (2007) The equilibria that allow bacterial persistence in human hosts. Nature, 449, 843-849. doi:10.1038/nature06198
[12] Blaser, M.J. and Falkow, S. (2009) What are the consequences of the disappearing human microbiota? Nature Reviews Microbiology, 7, 887-894. doi:10.1038/nrmicro2245
[13] Curtis, M.M. and Way, S.S. (2009) Interleukin-17 in host defense against bacterial, mycobacterial and fungal pathogens. Immunology, 126, 177-185. doi:10.1111/j.1365-2567.2008.03017.x
[14] Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., et al. (2007) Phenotypic and functional features of human Th17 cells. The Journal of Experimental Medicine, 204, 1849-1861. doi:10.1084/jem.20070663
[15] Blaser, M.J., Chen, Y. and Reibman, J. (2008) Does Helicobacter pylori protect against asthma and allergy? Gut, 57, 561-567. doi:10.1136/gut.2007.133462
[16] Koenen, H.J., Smeets, R.L., Vink, P.M., van Rijssen, E., Boots, A.M. and Joosten, I. (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood, 112, 2340-2352. doi:10.1182/blood-2008-01-133967
[17] Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C.M., Knight, R. and Gordon, J.I. (2007) The human microbiome project. Nature, 449, 804-810. doi:10.1038/nature06244
[18] Jukes, T. (2012) Antibiotics in animal feeds and production. Bioscience, 22, 526-534. doi:10.2307/1296312
[19] Albrich, W.C., Baughman, W., Schmotzer, B. and Farley, M.M. (2007) Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clinical Infectious Diseases, 44, 1569-1576. doi:10.1086/518149
[20] Regev-Yochay, G., Dagan, R., Raz, M., Carmeli, Y., Shainberg, B., Derazne, E., et al. (2004) Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA, 292, 716-720. doi:10.1001/jama.292.6.716
[21] Regev-Yochay, G., Bogaert, D., Malley, R., Hermans, P.W., Veenhoven, R.H., Sanders, E.A., et al. (2008) Does pneumococcal conjugate vaccine influence Staphylococcus aureus carriage in children? Clinical Infectious Diseases, 47, 289-291. doi:10.1086/589573
[22] Rasko, D.A., Moreira, C.G., Li, D.R., Reading, N.C., Ritchie, J.M., Waldor, M.K., et al. (2008) Targeting QseC signaling and virulence for antibiotic development. Science, 321, 1078-1080. doi:10.1126/science.1160354
[23] Schneider, D.S. and Ayres, J.S. (2008) Two ways to survive infection: What resistance and tolerance can teach us about treating infectious diseases. Nature Reviews Immunology, 8, 889-895. doi:10.1038/nri2432
[24] Lamkanfi, M. (2011) Emerging inflammasome effector mechanisms. Nature Reviews Immunology, 11, 213-220. doi:10.1038/nri2936
[25] Chu, J., Thomas, L.M., Watkins, S.C., Franchi, L., Nunez, G. and Salter, R.D. (2009) Cholesterol-dependent cytolysins induce rapid release of mature IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner. Journal of Leukocyte Biology, 86, 1227-1238. doi:10.1189/jlb.0309164
[26] Dostert, C., Guarda, G., Romero, J.F., Menu, P., Gross, O., Tardivel, A., et al. (2009) Malarial hemozoin is a Nalp3 inflammasome activating danger signal. The Public Library of Science One, 9, e6510.
[27] Gurcel, L., Abrami, L., Girardin, S., Tschopp, J., van der Goot, F.G. (2006) Caspase-1 activation of lipid metabolic pathways in response to bacterial poreforming toxins promotes cell survival. Cell, 126, 1135-1145. doi:10.1016/j.cell.2006.07.033
[28] Thomas, P.G., Dash, P., Aldridge, J.R., Ellebedy, A.H., Reynolds, C., Funk, A.J., et al. (2009) The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity, 30, 566-575. doi:10.1016/j.immuni.2009.02.006
[29] Cassel, S.L., Eisenbarth, S.C., Lyer, S.S., Sadler, J.J., Colegio, O.R., Tephly, L.A., et al. (2008) The NALP3 inflammasome is essential for the development of silicosis. Proceeding of the National Academy Sciences of the USA,105, 9035-9040. doi:10.1073/pnas.0803933105
[30] Dostert, C., Petrilli, V., van Bruggen, R., Steele, C., Mossman, B.T. and Tschopp, J. (2008) Innate immune activation through NALP3 inflammasome sensing of asbestos and silica. Science, 320, 674-677. doi:10.1126/science.1156995
[31] Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L., et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature Immunology, 9, 847- 856. doi:10.1038/ni.1631
[32] Gasse, P., Riteau, N., Charron, S., Girre, S., Fick, L., Petrilli, V., et al. (2009) Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. American Journal of Respiratory and Critical Care Medicine, 179, 903-913. doi:10.1164/rccm.200808-1274OC
[33] Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O’Rourke, K., Roose-Girma, M., et al. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature, 440, 228-232. doi:10.1038/nature04515
[34] Salminen, A., Ojala, J., Suuronen, T., Kaarniranta, K. and Kauppinen, A. (2008) Amyloid-β oligomers set fire to inflammasomes and induce Alzheimer’s pathology. Journal of Cellular and Molecular Medicine, 12, 2255-2262. doi:10.1111/j.1582-4934.2008.00496.x
[35] Yamasaki, K., Muto, J., Taylor, K.R., Cogen, A.L., Audish, D., Bertin, J., et al. (2009) NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. The Journal of Biological Chemistry, 284, 12762-12771. doi:10.1074/jbc.M806084200
[36] Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J., et al. (2011) NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell, 145, 745-757. doi:10.1016/j.cell.2011.04.022
[37] Thacker, J.D., Sassi-Gaha, S., Stephens, C., Purohit, M., Rest, R.F. and Artlett, C.M. (2012) NLRP3 Inflammasome is a target for development of broad-spectrum anti-infective drugs. Antimicrobial Agents Chemotherapy, 56, 1921-1930. doi:10.1128/AAC.06372-11
[38] Henan-Mejia, I., Elinav, E., Strowig, T. and Flavell, R.A. (2012) Inflammasomes: Far beyond inflammation. Nature Immunology, 13, 321-324. doi:10.1038/ni.2257
[39] Franchi, L., Mu?oz-Planillo, R. and Nú?ez, G. (2012) Sensing and reacting to microbes through inflammasomes. Nature Immunology, 13, 325-332. doi:10.1038/ni.2231
[40] Zitvogel, L., Kepp, O., Galluzzi, L. and Kroemer, G. (2012) Inflammasomes in carcinogenesis and anticancer immune responses. Nature Immunology, 13, 343-351. doi:10.1038/ni.2224

comments powered by Disqus

Copyright © 2014 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.